ChromaDex Investor Presentation 2021

ChromaDex is a global bioscience company pioneering research on NAD+ and its precursors, particularly nicotinamide riboside (NR), commercialized as Niagen®. The company markets Tru Niagen® as a consumer product focused on healthy aging through partnerships with global retailers and distributors.